AndrewMDavidMAdamsM, et al. Venous thromboembolic complications in children: first analyses of Canadian Registry of VTE. Blood. 1994;83:1251-1257.
2.
SteinPDKayaliFOlsonRE.Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr. 2004;145:563-565.
3.
SobrieraMLRogattoSRDos SantosRMSantosITFerrariICYoshidaWB.An unexpectedly high rate of thrombophilia disorders in patients with superficial vein thrombosis of the lower extremities. Ann Vasc Surg. 2017;43:272-277.
4.
TuranOÜndarBGunaryTAkkocluA.Investigation of inherited thrombophilias in patients with pulmonary embolism. Blood Coagul Fibrinolysis. 2012;24:140-149.
5.
MistryDAChandratreyaALeePYF.A systematic review on the use of aspirin in the prevention of deep vein thrombosis in major elective lower limb orthopedic surgery: an update from the past 3 years. Surg J (N Y). 2017;3:e191-e196.
6.
MarikPECavallazziR.Extended anticoagulant and aspirin treatment for the secondary prevention of thromboembolic disease: a systematic review and meta-analysis. PLoS One. 2015;10:e0143252.
7.
von VajnaEAlamRSoTY.Current clinical trials on the use of direct oral anticoagulants in the pediatric population. Cardiol Ther. 2016;5:19-41.
8.
DabbousMKSakrFRMalaebDN.Anticoagulant therapy in pediatrics. J Basic Clin Pharm. 2014;5:27-33.
9.
EldredgeJBSpyropoulosAC.Direct oral anticoagulants in the treatment of pulmonary embolism. Curr Med Res Opin. 2018;34:131-140.
10.
DickersonKESarodeRZiaA.Safety and feasibility of treatment with rivaroxaban in children for non-routine indications: a case series analysis. Blood. 2016;128:5014-5036.
11.
GigliaTMMassicotteMPTweddellJS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;138:2622-2703.
12.
AghaBSSturmJJSimonJKHirschDA.Pulmonary embolism in the pediatric emergency department. Pediatrics. 2013;132:663-667.
13.
HennellyKEBaskinMNMonuteauxMC, et al. Detection of pulmonary embolism in high-risk children. J Pediatr. 2016;178:214-218.
14.
SharafNSharafVBMaceSENawackiASStollerJKCarlJC.D-dimer in adolescent pulmonary embolism. Acad Emerg Med. 2018;25:1235-1241.
15.
BissTTBrandãoLRKahrWHChanAKWilliamsS.Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008;142:808-818.
16.
RamizSRajpurkarM.Pulmonary embolism in children. Pediatr Clin North Am. 2018;65:495-507.
17.
GoelRNessPMTakemotoCMKrishnamurtiLKingKETobianA.Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood. 2015;125:1470-1476.
18.
GoldenbergNAAbshireTBlatchfordPJ, et al. Multicenter randomized controlled trial on duration of therapy for thrombosis in children and young adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015;13:1597-1605.
19.
GoelRVedanthamSGoldenbergNA.Antithrombotic therapies: anticoagulation and thrombolysis. Pediatr Clin North Am. 2013;60:1463-1474.
20.
AlbisettiM.Thrombolytic therapy in children. Thromb Res. 2006;118:95-105.